BT200 in Hereditary Bleeding Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hemophilia A
Related studies linked through entity extraction aliases.
ASC618 Gene Therapy in Hemophilia A Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
National Longitudinal Cohort of Hematological Diseases
- Status
- RECRUITING
- Phase
- N/A
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Preventing Inhibitor Recurrence Indefinitely
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Pulsed Electromagentic Field in Haemophilia
- Status
- UNKNOWN
- Phase
- NA
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis
- Status
- UNKNOWN
- Phase
- N/A
A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE4
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A
- Status
- COMPLETED
- Phase
- N/A
Medication Adherence and Non-adherence in Adults With Rare Disease
- Status
- WITHDRAWN
- Phase
- N/A
Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
UPLC-MS/MS Monitoring of Emicizumab Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.
- Status
- COMPLETED
- Phase
- PHASE3
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
PHYSICAL ACTIVITY AND FVIII CLEARANCE: RELEVANCE FOR PERSONALIZED THERAPY IN SEVERE HAEMOPHILIA A (PHYSEMO)
- Status
- UNKNOWN
- Phase
- NA